MOVERS

RENEURON 154p +27.3%

The biotech firm soared after a positive update on progress with a US clinical trial on a therapeutic aimed at a eye disease retinitis pigmentosa.

SAGA 67.3p -37.5%

Shares in the over50s insurance and holiday firm plunged after it warned over profits for the coming year amid an overhaul to return to growth.